| KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2 JB Rivière, S Ramalingam, V Lavastre, M Shekarabi, S Holbert, ... The American Journal of Human Genetics, 2011 | 203 | 2011 |
| Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect J Senderek, JS Muller, M Dusl, TM Strom, V Guergueltcheva, I Diepolder, ... The American Journal of Human Genetics 88 (2), 162-172, 2011 | 182 | 2011 |
| Quality of life of people with epilepsy in Iran, the Gulf, and Near East GA Baker, A Jacoby, J Gorry, J Doughty, V Ellina, SIGN Group Epilepsia 46 (1), 132-140, 2005 | 173 | 2005 |
| COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) S Muppidi, JT Guptill, S Jacob, Y Li, ME Farrugia, AC Guidon, JO Tavee, ... The Lancet Neurology 19 (12), 970-971, 2020 | 118 | 2020 |
| Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial M Ahmadi, E Agah, S Nafissi, MR Jaafari, MH Harirchian, P Sarraf, ... Neurotherapeutics 15 (2), 430-438, 2018 | 109 | 2018 |
| International clinimetric evaluation of the MGQOL15, resulting in slight revision and subsequent validation of the MGQOL15r TM Burns, R Sadjadi, K Utsugisawa, KG Gwathmey, A Joshi, S Jones, ... Muscle & nerve 54 (6), 1015-1022, 2016 | 104 | 2016 |
| Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations V Guergueltcheva, JS Müller, M Dusl, J Senderek, A Oldfors, C Lindbergh, ... Journal of neurology 259 (5), 838-850, 2012 | 95 | 2012 |
| Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients P Ghiasi, S Hosseinkhani, A Noori, S Nafissi, K Khajeh Neurological research 34 (3), 297-303, 2012 | 86 | 2012 |
| Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients: a double-blind placebo-controlled clinical trial S Bitarafan, A Saboor-Yaraghi, MA Sahraian, D Soltani, S Nafissi, ... Iranian Journal of Allergy, Asthma and Immunology 15 (1), 13-19, 2016 | 75 | 2016 |
| Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations I Wargon, P Richard, T Kuntzer, D Sternberg, S Nafissi, K Gaudon, ... Neuromuscular Disorders 22 (4), 318-324, 2012 | 74 | 2012 |
| Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis P Ayatollahi, S Nafissi, MR Eshraghian, H Kaviani, A Tarazi Multiple Sclerosis 13 (2), 275-277, 2007 | 67 | 2007 |
| Complex I and ATP content deficiency in lymphocytes from Friedreich's ataxia MM Heidari, M Houshmand, S Hosseinkhani, S Nafissi, M Khatami Canadian journal of neurological sciences 36 (1), 26-31, 2009 | 66 | 2009 |
| Wilson’s disease: a great masquerader A Soltanzadeh, P Soltanzadeh, S Nafissi, A Ghorbani, H Sikaroodi, J Lotfi European Neurology 57 (2), 80-85, 2007 | 65 | 2007 |
| Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome S Yadegari, S Nafissi, N Kazemi Iranian Journal of Neurology 13 (3), 138-143, 2014 | 59 | 2014 |
| Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients S Bitarafan, MH Harirchian, S Nafissi, MA Sahraian, M Togha, F Siassi, ... Iranian journal of neurology 13 (1), 28, 2014 | 57 | 2014 |
| Identification of mutation in GTPBP2 in patients of a family with neurodegeneration accompanied by iron deposition in the brain E Jaberi, M Rohani, GA Shahidi, S Nafissi, E Arefian, M Soleimani, ... Neurobiology of Aging 38, 216. e11-216. e18, 2016 | 55 | 2016 |
| Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis. S Bitarafan, A Saboor-Yaraghi, MA Sahraian, S Nafissi, M Togha, ... Archives of Iranian medicine 18 (7), 435-440, 2015 | 54 | 2015 |
| Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population Z Fattahi, Z Kalhor, M Fadaee, R Vazehan, E Parsimehr, A Abolhassani, ... Clinical genetics 91 (3), 386-402, 2017 | 50 | 2017 |
| Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained … K Johnson, M Bertoli, L Phillips, A Töpf, P Van den Bergh, J Vissing, ... Skeletal muscle 8 (1), 23, 2018 | 48 | 2018 |
| Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix … M Momeny, M Malehmir, M Zakidizaji, R Ghasemi, H Ghadimi, ... Anti-cancer drugs 21 (3), 252, 2010 | 48 | 2010 |
Farzad FatehiProfessor of Neurology, Shariati Hospital, Tehran university of medical sciences在 tums.ac.ir 的电子邮件经过验证
